Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE
Breast Cancer Res 2008, 10:R86
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Hypothesis    
JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?
Coelho TR, Almeida L, Lazo PA
Virology Journal 2010, 7:42 (18 February 2010)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Research article    
Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer
Dahl E, En-Nia A, Wiesmann F, Krings R, Djudjaj S, Breuer E, Fuchs T, Wild PJ, Hartmann A, Dunn SE, Mertens PR
BMC Cancer 2009, 9:410 (24 November 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.


Editorial    
Approaches towards expression profiling the response to treatment
Sims AH, Bartlett JMS
Breast Cancer Research 2008, 10:115 (8 December 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
4.


Research article    
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Stratford AL, Fry CJ, Desilets C, Davies AH, Cho YY, Li Y, Dong Z, Berquin IM, Roux PP, Dunn SE
Breast Cancer Research 2008, 10:R99 (27 November 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.